WuXi XDC Cayman Inc (02268.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

20.5x

EV/EBITDA

20.1x

Market Cap

HKD 88.50B

MomentumView details →

1D Return

−0.41%

YTD Return

+20.33%

RSI (14)

60.2

ValuationView details →

P/E (Fwd)

20.5x

EV/EBITDA

20.1x

Market Cap

HKD 88.50B

RSI (14)

60.2

MomentumView details →

1D Return

−0.41%

YTD Return

+20.33%

ProfitabilityView details →

Gross Margin

35.02%

Net Margin

23.94%

EBITDA Margin

29.47%

ROE (TTM)

25.39%

ROA (TTM)

18.48%

Asset Turnover

0.80x

GrowthView details →

Revenue YoY

+169.25%

EPS YoY

+225.04%

FCF YoY

+160.49%

Revenue CAGR 3Y

+81.73%

EPS CAGR 3Y

+110.93%

EBITDA YoY

+280.44%

EarningsView details →

EPS (Actual)

HKD 0.59

EPS Surprise

−13.03%

Beats (12Q)

0/12

Next Q EPS Est

HKD 0.78

Avg Surprise (4Q)

−13.03%

Rev Surprise

−13.61%

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

2.37x

Quick Ratio

2.28x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

11.98B

Net Income (TTM)

2.87B

Op. CF (TTM)

2.76B

Next earningsMar 29, 2027 →

Latest newsMore news →

WuXi AppTec sold 53.524 million shares of WuXi XDC via block trades for about HK$3.92 billion, expecting an impact of about 3.143 billion yuan on 2026 pre-tax profit.8d ago

WuXi XDC signed a new licensing collaboration with a European biotech company in August 2026.10d ago

Similar companies

Access Bio, Inc.950130.KQ Danaher CorporationDHR Natera, Inc.NTRA IQVIA Holdings Inc.IQV Agilent Technologies, Inc.A IDEXX Laboratories, Inc.IDXX Find similar companies →

Latest newsMore news →

WuXi AppTec sold 53.524 million shares of WuXi XDC via block trades for about HK$3.92 billion, expecting an impact of about 3.143 billion yuan on 2026 pre-tax profit.8d ago WuXi XDC signed a new licensing collaboration with a European biotech company in August 2026.10d ago